| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/08/2001 | EP1121435A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121427A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 08/08/2001 | EP1121426A2 Method for triggering apoptosis in cells |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP1121381A2 Zinc finger binding domains for gnn |
| 08/08/2001 | EP1121376A1 Pregnane glucuronides |
| 08/08/2001 | EP1121363A2 6-SUBSTITUTED PYRAZOLO 3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 08/08/2001 | EP1121362A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 08/08/2001 | EP1121359A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 08/08/2001 | EP1121349A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 08/08/2001 | EP1121157A1 A novel component in the hedgehog signalling pathway |
| 08/08/2001 | EP1121156A2 Polymer conjugates of interferon beta- 1a and their uses |
| 08/08/2001 | EP1121153A1 Site-specific labeling of disulfide-containing targeting vectors |
| 08/08/2001 | EP1121137A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 08/08/2001 | EP1121133A1 Methods for stimulating bone formation |
| 08/08/2001 | EP1121118A1 Formamides as therapeutic agents |
| 08/08/2001 | EP1121117A2 Oxaliplatinum preparation packaging |
| 08/08/2001 | EP1121113A1 Methods for regulating bone formation |
| 08/08/2001 | EP1121111A2 Compounds for the treatment of weight loss |
| 08/08/2001 | EP1121107A2 Sertraline oral concentrate |
| 08/08/2001 | EP1121102A1 Liposome-entrapped topoisomerase inhibitors |
| 08/08/2001 | EP1044005A4 1,2,4-benzotriazine oxides formulations |
| 08/08/2001 | EP1019037B1 Medicament containing delta-aminolevulinic acid |
| 08/08/2001 | EP0837878B1 Antitumor proteins from rana pipiens oocytes |
| 08/08/2001 | CN1307637A Polynucleotides isolated from skin cells and methods for their use |
| 08/08/2001 | CN1307584A Macrolide LHRH antagonists |
| 08/08/2001 | CN1307580A Syntheses of variety of lamellarin compounds and analogues |
| 08/08/2001 | CN1307564A Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 08/08/2001 | CN1307561A Novel VLA-4 inhibitor: oMePUPA-V |
| 08/08/2001 | CN1307482A Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/08/2001 | CN1307473A Triterpene compositions and methods for use thereof |
| 08/08/2001 | CN1307060A Method for purifying and high-efficiency expression of human hemangio-endothelia inhibin the Pasteur-Pichia yeast and use of said inhibin in treatment of antineoplastic vasopropagation |
| 08/08/2001 | CN1307037A Polypeptide-human zinc finger protein 14 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1307036A Polypeptide-human split compound 69 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1307031A Polypeptide-human zinc finger protein 19 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1307019A Polypeptide-human zinc finger protein 49 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1307017A Polypeptide-human zinc finger protein 46 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1307013A Polypeptide-human zinc finger protein 13 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306979A Polypeptide-robosomal protein L20, 16 and polynucleotide for coding said polypeptide |
| 08/08/2001 | CN1306860A Composition and preparation of human tumor antigen-mycobacterium heat shock protein tumor vaccine |
| 08/08/2001 | CN1306859A Preparation of antineoplastic immune vaccine |
| 08/08/2001 | CN1306854A Water extracted and alcohol precipitated matter of subprostrate sophora and its application in medicine |
| 08/08/2001 | CN1306824A Water soluble medical chitose preparation and its preparation |
| 08/08/2001 | CN1069319C Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 08/08/2001 | CN1069316C Substituted 5-ring heterocycles, their preparation and use |
| 08/08/2001 | CN1069312C Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 08/08/2001 | CN1069205C Anticancer drug and its prep |
| 08/08/2001 | CN1069200C Medicine made from plum and apricot and production method thereof |
| 08/07/2001 | US6271384 Self-assembled taxo-diterpenoid nanostructures |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271365 Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding them |
| 08/07/2001 | US6271342 Sugar-modified cytostatics |
| 08/07/2001 | US6271262 Metalloproteinase inhibitors |
| 08/07/2001 | US6271257 Decreasing the intracellular level of β-catenin by administering hydroxymatairesinol |
| 08/07/2001 | US6271253 Cyclooxygenase inhibitors |
| 08/07/2001 | US6271250 Metal Glycididaagolc, and preparation and uses thereof |
| 08/07/2001 | US6271248 Substituted biphenysulfonamide endothelin antagonists |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/07/2001 | US6271242 Adminstering (8r*,9s*,11s*)-(-)-9-hydroxy-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro -8,11-epoxy-(1h, 8h, 11h) 2, 7b, 11a-triazadibenzo(a, g)cycloocta(c,d,e)triinden-1-one as treatment of cancer induced by trk oncogene protein |
| 08/07/2001 | US6271217 Method of treating cancer with a benzimidazole and a chemotherapeutic agent |
| 08/07/2001 | US6271210 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer |
| 08/07/2001 | US6271209 Cationic lipid formulation delivering nucleic acid to peritoneal tumors |
| 08/07/2001 | US6271030 For modulation of c/ebp beta (transcription factor enhancer-binding gene) expression and for treatment of diseases associated with expression of c/ebp beta |
| 08/07/2001 | US6271019 Leukemia associated genes |
| 08/07/2001 | US6271017 Genes of Heliciobacter pylori necessary for the regulation and maturation of urease and their use |
| 08/07/2001 | US6270993 VEGF-binding polypeptide |
| 08/07/2001 | US6270778 Relates to genes encoding melanoma antigens recognized by t-cells and their corresponding proteins. |
| 08/07/2001 | US6270768 Azithromycins |
| 08/07/2001 | US6270765 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 08/07/2001 | US6270759 Method of using IL-11 for treating gingivitis |
| 08/07/2001 | CA2139217C Vaccine composition for eliciting an immune response against n-glycolylated gangliosides and its use for cancer treatment |
| 08/07/2001 | CA2104782C 1-substituted, 2-substituted 1h-imidazo-[4,5-c]quinolin-4- amines |
| 08/07/2001 | CA2085345C Pyrimidine nucleoside derivatives |
| 08/07/2001 | CA2025607C Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents |
| 08/07/2001 | CA1341281C Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen |
| 08/02/2001 | WO2001055692A2 Neurosteroids as markers for alzheimer's disease |
| 08/02/2001 | WO2001055432A2 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 08/02/2001 | WO2001055392A2 Nuclear hormone receptors |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055389A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 08/02/2001 | WO2001055385A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | WO2001055358A2 Phosphodiesterases |
| 08/02/2001 | WO2001055357A2 Myeloid colony stimulating factor and uses thereof |
| 08/02/2001 | WO2001055356A2 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | WO2001055337A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055333A2 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055221A1 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 08/02/2001 | WO2001055219A2 scsCNTFR/NNT-1 FUSION PROTEIN |
| 08/02/2001 | WO2001055210A2 Human cyr61 |
| 08/02/2001 | WO2001055188A1 A new polypeptide-human zinc finger protein 46 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055187A1 A new polypeptide-zinc finger protein 49 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055186A1 A new polypeptide-human zinc finger protein 14 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055185A1 A new polypeptide-ribosome protein l20,16 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055184A1 A new polypeptide-human zinc finger protein 19 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | WO2001055172A2 ISOLATED COMPLEX COMPRISING A NNT-1 PROTEIN AND IN ADDITION AT LEAST A CLF-1 PROTEIN AND/OR A sCNTFRα PROTEIN |